Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alfred Altomari Insider Profile
4 Followers
Alfred Altomari, CEO, Director at Agile Therapeutics, holds 47.75K shares in Agile Therapeutics (Ticker: AGRX), holds 56.33K shares in Insmed (Ticker: INSM), holds 117.78K shares in Baudax Bio (Ticker: BXRXQ).
Alfred Altomari Agile Therapeutics (AGRX)CEO, Director
Agile Therapeutics (AGRX)
CEO, Director
Ranked #93,836 out of 98,624 Corporate Insiders
Profitable Transactions
6 out of 19 Profitable Transactions
Average Return
-29.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Alfred Altomari holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 11, 2019 - Jun 11, 2020
Return:+101.50%
The most profitable trade made by Alfred Altomari
Alfred Altomari's Trading History
Agile Therapeutics
Jun 30, 2023
CEO, Director
Uninformative Buy
―
$18.34K
Baudax Bio
Apr 08, 2021
Director
Uninformative Buy
―
$1.18K
Insmed
May 15, 2023
Director
Uninformative Buy
―
$1.44M
Societal CDMO
Dec 09, 2019
―
Uninformative Buy
―
$48.62K
Auxilium
―
―
―
―
List of latest transactions for each holding click on a transaction to see Alfred Altomari's performance on stock
You May Also Like
Alfred Altomari insider profile FAQ
What is the percentage of profitable transactions made by Alfred Altomari?
The percentage of profitable transactions made by Alfred Altomari is 32%.
What is the average return per transaction made by Alfred Altomari?
The average return per transaction made by Alfred Altomari is -29.70%.
What stocks does Alfred Altomari hold?
Alfred Altomari holds: AGRX, BXRXQ, INSM, SCTL, AUXL stocks.
What was Alfred Altomari’s latest transaction?
Alfred Altomari latest transaction was an Uninformative Buy of ―.
What was Alfred Altomari's most profitable transaction?
Alfred Altomari’s most profitable transaction was an Informative Buy of AGRX stock on June 11, 2019. The return on the trade was 101.50%.
What is Alfred Altomari's role in Agile Therapeutics?
Alfred Altomari's role in Agile Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.